Key Takeaways
- A tough year, but not a lost one: Revenue grew 10% and EBITDA grew at the same rate or slightly better, even as chemical markets stayed slow and Europe execution lagged.
- Order intake surged 20%, powered by non-traditional industries: Nearly 50% of orders came from outside the core chemical and pharma base, including a INR 130 crores nuclear order and a USD 30 million acid recovery win.
- Restructuring is finally delivering hard numbers: German headcount reductions will save INR 45 crores annually, the Poland low-cost hub is at full capacity, and exceptional costs are largely behind the company.
- The balance sheet remains the overhang: INR 600+ crores of cash sits against high interest costs of INR 120-130 crores, and the inherited financing structure will take at least another year to untangle.
- What to watch next quarter: Whether the strong Q1 order intake momentum holds, the pace of debt restructuring execution under the new Deputy CFO, and any concrete numbers from the three-year strategic plan promised for August-September.
Demand & Order Intake
- Non-traditional industries are now the growth engine: Nearly 50% of order intake came from defense, oil and gas, nuclear, semiconductors, and international exports, a deliberate diversification away from the slow chemical and pharma core.
- Two large systems orders drove the 20% intake jump: One in the U.S. and one in Eastern Europe, with management seeing an open opportunity pipeline in Europe that could generate USD 20-30 million of systems orders per year over the next few years.
- Traditional markets remain patchy: Chemicals are slow in Europe and India, with agrochemicals and Chinese overcapacity weighing on demand; pharma and CDMO/peptide activity is picking up in India, but big projects are few and far between.
- Edlon and SEMCO are bright spots: Edlon (semiconductor and nuclear) has reached USD 25 million in revenue at high margins; SEMCO in South America and MixPro in Canada are benefiting from metals and minerals investment cycles.
- Europe order intake improved, setting up next year: While execution in Europe was slow this year, stronger order intake provides a base for recovery.
Tarak Patel: "Nearly 50% of our order intake this year has come from non-traditional industries. So, when I say non-traditional, these are non-chemical and non-pharma."
Restructuring & Cost Savings
- German restructuring is complete and quantified: A signed agreement with all individuals will deliver INR 45 crores in annual savings, though the full-year impact will not be realized from April because departures are staggered through the year.
- European footprint rationalized: The UK Leven facility was shut down, headcount was reduced across Germany, France, and Switzerland, and the Poland plant is now commissioned and running at full capacity as a low-cost hub for Europe.
- Exceptional costs are largely done: INR 65 crores in exceptional items this year covered German severance and India labor code impacts; management stated no significant one-off costs are planned next year.
- Poland expansion is urgent: The GMM Inox facility is at full capacity and needs two more sheds built as soon as possible; management holds 51% with an option to acquire 100% later but currently prefers the strong local partner.
- India heavy engineering is scaling: The Vatva facility grew double-digits YoY to INR 300+ crores in revenue and can reach INR 700-800 crores with only small incremental investment.
Margins & Profitability
- Q4 gross margins dipped on mix, not trend: Gross margin fell to 55.4% due to a large heavy engineering order shipped in the quarter, plus increases in gas and metal prices; management cautioned against reading a single quarter in isolation for a manufacturing company with a wide product range.
- Full-year margin story is positive: EBITDA rose from INR 361 crores to INR 403 crores, with margin percentage up 1 percentage point on a 12-month basis despite the tough environment.
- 15% EBITDA margin is the medium-term floor: Management believes 15% is the minimum to aspire to, with 16-17% achievable if initiatives work; the company exited the year at roughly 11.5%.
- Cost structure is resetting lower: The company will operate with a much lower cost base next year, with low-hanging fruit still being worked on and further improvement expected from backlog, operational improvements, and restructuring.
- Flow-through from EBITDA to PAT is a recognized problem: High interest costs and tax inefficiencies have created a meager conversion; the new Deputy CFO was hired specifically to create the right structure and improve this.
Tarak Patel: "So, even in a tough year, we have grown 10% revenue and what is even better is our profitability at the EBITDA level has grown at the same rate or slightly better. So, we haven't lost a lot."
Balance Sheet & Debt Restructuring
- The cash-and-debt paradox: The company holds INR 600-680 crores of cash but carries high interest costs of INR 120-130 crores, a structure inherited from the Pfaudler acquisition involving intercompany loans and a Luxembourg entity across 18 jurisdictions.
- Restructuring is slow by management's own admission: A Big Four firm spent six months identifying options, Board approval is now in place to change the intercompany loan and Luxembourg setup, but the CFO refused to confirm it will be settled by the end of this financial year.
- USD 20 million debt repayment is the near-term target: Management intends to repay this amount from the group to reduce both the cash and debt position, though some cash must be retained to finance large contracts requiring customer prepayments.
- Tax rate is improving but still elevated: The international business tax rate moved closer to expectations this quarter, now in the 30% area; the high rate stems from the Luxembourg entity and FX exposure on a German-Luxembourg intercompany loan.
- Pension provision increase is non-cash: The INR 110 crores increase in provisions is purely an actuarial valuation adjustment driven by interest rate assumptions; the plans are closed and there is no cash outflow.
Alexander Poempner: "I know that it takes long. But unfortunately, to change these setups, it takes a little bit longer. It was inherited. We are working on this. We get some Board approval to continue now with the proposed measures. But I do not want to confirm that it is settled, solved by end of this financial year."
Strategic Direction & Leadership
- New Group CEO appointed: Gregory Gelhaus has taken the top role, and Ankit Nayyar joined as Deputy CFO to work on the EBITDA-to-PAT conversion structure.
- Three-year strategic plan is in development: The Board held a strategy meeting and has broad-level numbers and initiatives in place; management plans to present to the market in August-September but will delay if they lack confidence in the numbers.
- New reporting system coming next quarter: A reorganized reporting structure with clearer data will be introduced, reflecting the new organizational thinking.
- Growth ambition is realistic, not heroic: Management explicitly rejected a 20% YoY growth narrative, saying certain geographies will grow fast and some slow; the plan is for at least double-digit growth over the next three years.
- Non-traditional industries are the deliberate future: The organization is being built to capture more defense, nuclear, oil and gas, and semiconductor work, with management believing growth will come from these segments.
Tarak Patel: "The last thing we want is to come out and give a number and then not achieve it."
Segment & Regional Performance
| Segment / Region | Trend | Commentary |
|---|---|---|
| Heavy Engineering (Vatva) | ▲ Strong | Double-digit YoY growth to INR 300+ crores; can scale to INR 700-800 crores with small investment. |
| Edlon (semiconductor/nuclear) | ▲ Strong | Reached USD 25 million revenue at high margins; secured INR 130 crores nuclear order. |
| SEMCO (South America) & MixPro (Canada) | ▲ Good | Benefiting from metals and minerals investment cycles. |
| Europe (execution) | ▼ Slow | Execution lagged, but order intake improved, setting up a stronger next year. |
| Chemicals (global) | ▼ Slow | Slow and patchy, especially in Europe; India slowed by agrochemicals and Chinese overcapacity. |
| Pharma/CDMO/peptide (India) | ▲ Picking up | Activity increasing, though big projects remain few. |
| China | ▬ Recovering | Business has come back this quarter; no closure planned. |
| Poland (GMM Inox) | ▲ At capacity | Running full; two more sheds needed as soon as possible. |
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | At least double-digit growth | Over the next three years |
| EBITDA margin | 15% minimum, 16-17% achievable if initiatives work | Medium term |
| German restructuring savings | INR 45 crores annual savings, staggered as people retire | Starting next year, full impact beyond FY27 |
| Debt repayment | Repay USD 20 million from the group | Not specified |
| Financing restructuring | Reorganize intercompany loan and Luxembourg entity setup | Within the next calendar year; not confirmed settled by FY27-end |
| Tax and FX restructuring | Complete general restructuring and intercompany loan cleanup | Next year |
| Strategic plan presentation | Present three-year plan with numbers to capital markets | August-September, or a couple of months later if not ready |
| Exceptional costs | No significant one-off costs planned | Next year (as of now) |
| Poland expansion | Build two more sheds | As soon as possible |
| Vatva capacity | Reach INR 700-800 crores revenue with small investment | Not specified; beyond that needs new facility |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Revenue growth | ~17% YoY and ~7% QoQ |
| Full-year revenue growth | ~10% YoY |
| Full-year EBITDA | ₹403 cr, up from ₹361 cr reported last year |
| Full-year EBITDA margin | Up 1 ppt on a 12-month basis |
| Consolidated gross margin | 55.4% |
| Full-year order intake | ₹3,714 cr, up 20% YoY from ₹3,100 cr |
| Opening backlog (April 1) | Up ~34% YoY |
| Order intake from non-traditional industries | ~50% of total order intake |
| Free cash flow | ₹367 cr, up ₹49 cr vs prior year |
| Free cash flow to EBITDA ratio | Slightly above 90% |
| Net debt to adjusted EBITDA | 0.4x, vs 0.5x previous year |
| Net debt to equity | 0.1 |
| Long-term debt repaid during the year | ₹60 cr |
| International business tax rate | ~30% |
| Annual cost savings from German restructuring | ₹45 cr on a full-year basis |
| Exceptional items | ₹65 cr (restructuring severance in Germany, impact on India labor code) |
| Heavy engineering revenue (Vatva) | ₹300+ cr for the year |
| Edlon business size | $25 mn, up from $10 mn a few years ago |